Cell surface antigens on rat islet tumors

Area of Science:

• Immunology
• Endocrinology
• Oncology

Background:

• Rat pancreatic beta cell tumors (RIN) possess antigenic properties that are crucial for understanding autoimmune responses in diabetes.
• Previous studies have faced challenges in utilizing RIN cells for diagnostic purposes due to variable antigen expression and nonspecific interactions.

Purpose of the Study:

• To investigate the antigenic characteristics of rat pancreatic beta cell tumors (RIN) using a cell surface enzyme-linked immunosorbent assay (CELISA).
• To evaluate the potential of RIN cells as targets for detecting autoantibodies associated with type I diabetes.

Main Methods:

• Utilized cell surface enzyme-linked immunosorbent assay (CELISA) to detect antibodies binding to RIN cells.
• Validated the assay using monoclonal antibodies against glycoproteins and glycolipids (ganglio and lacto series).
• Compared IgG antibody binding in sera from type I diabetics, normal controls, and unaffected siblings using RIN cells and rat hepatocytes as targets.

Main Results:

• CELISA detected antibodies targeting glycoproteins and glycolipids, primarily from the ganglio and lacto series.
• Sera from type I diabetics exhibited significantly greater IgG antibody binding to RIN cells at higher dilutions (1/30-1/120) compared to normal sera.
• Reactivity was not observed with rat hepatocytes, and prolonged culture of RIN cells led to decreased ganglioside expression and reduced binding.

Conclusions:

• Rat islet tumors express antigenic determinants recognized by autoantibodies found in type I diabetes.
• CELISA is a viable objective assay for detecting anti-islet antibodies, potentially overcoming diagnostic challenges related to antigen variability.
• Findings suggest RIN cells can serve as valuable tools for studying type I diabetes autoimmunity and developing diagnostic assays.